These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 7535490)
21. Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis. File SE Pharmacol Ther; 1990; 46(3):357-75. PubMed ID: 1971443 [TBL] [Abstract][Full Text] [Related]
22. Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. Juruena MF; Pariante CM; Papadopoulos AS; Poon L; Lightman S; Cleare AJ Br J Psychiatry; 2009 Apr; 194(4):342-9. PubMed ID: 19336786 [TBL] [Abstract][Full Text] [Related]
23. Novel agents in development for the treatment of depression. Grady MM; Stahl SM CNS Spectr; 2013 Dec; 18 Suppl 1():37-40; quiz 41. PubMed ID: 24252548 [TBL] [Abstract][Full Text] [Related]
24. [The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression]. Juruena MF; Cleare AJ; Pariante CM Braz J Psychiatry; 2004 Sep; 26(3):189-201. PubMed ID: 15645065 [TBL] [Abstract][Full Text] [Related]
25. Do antidepressants regulate how cortisol affects the brain? Pariante CM; Thomas SA; Lovestone S; Makoff A; Kerwin RW Psychoneuroendocrinology; 2004 May; 29(4):423-47. PubMed ID: 14749091 [TBL] [Abstract][Full Text] [Related]
26. The design of new antidepressants: can formal models help? A first attempt using a model of the hippocampal control over the HPA-axis based on a review from the literature. Belzung C; Billette de Villemeur E Behav Pharmacol; 2010 Dec; 21(8):677-89. PubMed ID: 21051994 [TBL] [Abstract][Full Text] [Related]
27. Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice. Thoeringer CK; Erhardt A; Sillaber I; Mueller MB; Ohl F; Holsboer F; Keck ME J Psychopharmacol; 2010 May; 24(5):733-43. PubMed ID: 19346277 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Pariante CM Ann N Y Acad Sci; 2009 Oct; 1179():144-52. PubMed ID: 19906237 [TBL] [Abstract][Full Text] [Related]
29. Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression. Schüle C; Baghai TC; Eser D; Rupprecht R Expert Rev Neurother; 2009 Jul; 9(7):1005-19. PubMed ID: 19589050 [TBL] [Abstract][Full Text] [Related]
30. JIEYUANSHEN DECOCTION EXERTS ANTIDEPRESSANT EFFECTS ON DEPRESSIVE RAT MODEL VIA REGULATING HPA AXIS AND THE LEVEL OF AMINO ACIDS NEUROTRANSMITTER. Qiuxia Z; Xinlong M; Yilong Y; Hui Z; Yali W; Xiaoquan Y; Lei W; Jiahui C; Haiyan Z Afr J Tradit Complement Altern Med; 2017; 14(2):33-46. PubMed ID: 28573220 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of imipramine and CORT118335 (Glucocorticoid receptor modulator/mineralocorticoid receptor antagonist) on brain-endocrine stress responses and depression-like behavior in female rats. Nguyen ET; Caldwell JL; Streicher J; Ghisays V; Balmer NJ; Estrada CM; Solomon MB Behav Brain Res; 2018 Jan; 336():99-110. PubMed ID: 28866130 [TBL] [Abstract][Full Text] [Related]
32. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms. Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084 [TBL] [Abstract][Full Text] [Related]
33. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277 [TBL] [Abstract][Full Text] [Related]